Holen Sie sich die Stockscreener-App
33.76
0.47%
-0.16
Handel nachbörslich:
33.76
Simplify Health Care Etf Aktie (PINK) Neueste Nachrichten
Nidec Announces the Establishment of the Executive Responsibility Investigation Committee - ChartMill
Asahi Kasei Begins Installation of Containerized Alkaline-Water Electrolyzer at Finland’s First Commercial Hydrogen Refueling Station - ChartMill
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients - AOL.com
CreativeOne Wealth LLC Grows Stock Holdings in Simplify Barrier Income ETF $SBAR - Defense World
Why (PINK) Price Action Is Critical for Tactical Trading - Stock Traders Daily
What's Going On With Biohaven Stock On Monday? - Benzinga
Is Simplify Health Care ETF stock a top hedge fund pickPortfolio Gains Summary & Stepwise Trade Execution Plans - Naître et grandir
Nidec Announces the Disclosure of the Third-Party Committee’s Investigation Report and Our Company’s Response - ChartMill
Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth - ChartMill
Lenovo Unveils Adaptive AI PCs, Modular Concepts, and Lenovo Qira Rollout at MWC 2026 - ChartMill
Understanding Momentum Shifts in (PINK) - Stock Traders Daily
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris - ChartMill
eDreams ODIGEO Grows Net Income Tenfold to €40.3 Million as Prime Reaches 7.8 Million Members - ChartMill
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds - ChartMill
How does Danaher Corporation’s stock stack up against other companies in the health care sector? - Bitget
How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks? - inkl
Yubico Unveils “YubiNation Partners”: A New Era of Global Channel Partnership to Secure Digital Identities in the Age of AI - ChartMill
KDDIY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving KDDI Corporation - ChartMill
Want To Simplify Investing? Buy These 2 ETFs And Let America Do The Work - Seeking Alpha
Lenovo Unlocks Data Potential with Next Generation of AI-Driven ThinkEdge Solutions - ChartMill
How well a cancer treatment works may depend on the time of day you get it - AOL.com
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer - AOL.com
How AI is speeding up cancer research - AOL.com
Researchers repurpose existing lung cancer drug to fight ovarian tumors - AOL.com
Soleus Adds a Significant Number of Celcuity Shares - AOL.com
Rob Lowe Wants More People to Join Cancer Clinical Trials. Here’s Why - AOL.com
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition - AOL.com
Warning: This Skyrocketing Stock Has a Hidden Risk - AOL.com
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes - AOL.com
Bolt Projects Holdings Announces Delisting From Nasdaq and SEC Deregistration - ChartMill
Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies - AOL.com
IEEE Recognizes Asahi Kasei Microdevices’ Commercialization of Thin-Film Hall Elements as an IEEE Milestone - ChartMill
Alset AI Provides Update on Loan Transaction of up to $3 Million - 富途牛牛
CSL licenses Eli Lilly's clazakizumab to cut cardiac risk in end-stage kidney disease - AOL.com
Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery - AOL.com
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases - ChartMill
1 Reason I'd Buy Eli Lilly Stock and Never Sell - AOL.com
Waystar Recognized as Inc. Best in Business for AI - GuruFocus
Waystar Recognized as Inc. Best in Business for AI – Company Announcement - Financial Times
Avoiding Lag: Real-Time Signals in (PINK) Movement - Stock Traders Daily
Will Simplify Health Care ETF stock justify high valuationJuly 2025 Institutional & Real-Time Volume Triggers - mfd.ru
Securities Fraud Investigation Into BYD Company Limited (BYDDF) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - ChartMill
Lenovo Group: Third Quarter Financial Results 2025/26 - ChartMill
KDDI CORPORATION INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - ChartMill
Securities Fraud Investigation Into KDDI Corporation (KDDIY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - ChartMill
Rosen Law Firm Encourages KDDI Corporation Investors to Inquire About Securities Class Action Investigation – KDDIY - ChartMill
Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know. - AOL.com
Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock? - AOL.com
VLVLY Investors Have Opportunity to Join AB Volvo Fraud Investigation with the Schall Law Firm - ChartMill
Eli Lilly Just Delivered Fantastic News to Shareholders - AOL.com
Crawford United Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crawford United CorporationCRAWA - ChartMill
Discipline and Rules-Based Execution in PINK Response - Stock Traders Daily
eDreams Prime Member Satisfaction Hits All-Time Record With Ratings +36% Higher Than Non-Subscribers in Key Market - ChartMill
Yubico Reveals 265% ROI and 99.99% Reduction in Risk of Exposure to Addressable Breach Risk Costs According to Total Economic Impact Study - ChartMill
Lenovo Expands its Ecosystem of Intelligent Meeting Rooms Solutions Through Deeper Integration of ThinkSmart Computing with Huddly Systems - ChartMill
PINK’s 58% Gains Since 2021 Come From Picking Winners, Not Owning Everything - AOL.com
PINK’s 58% gains since 2021 come from picking winners, not owning everything - MSN
Sharon AI to Deploy 1K B200 Cluster at NEXTDC M3 Data Center Using Lenovo Infrastructure and VAST Data - Chartmill
0.14%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):